792 related articles for article (PubMed ID: 27756212)
21. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
[TBL] [Abstract][Full Text] [Related]
22. Protection of swine by potent neutralizing anti-Japanese encephalitis virus monoclonal antibodies derived from vaccination.
Young CL; Lyons AC; Hsu WW; Vanlandingham DL; Park SL; Bilyeu AN; Ayers VB; Hettenbach SM; Zelenka AM; Cool KR; Peterson GJ; Higgs S; Huang YS
Antiviral Res; 2020 Feb; 174():104675. PubMed ID: 31825852
[TBL] [Abstract][Full Text] [Related]
23. Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection.
Kotaki T; Nagai Y; Yamanaka A; Konishi E; Kameoka M
Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146489
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
Woolpert T; Staples JE; Faix DJ; Nett RJ; Kosoy OI; Biggerstaff BJ; Johnson BW; Sracic M; Fischer M
Vaccine; 2012 Apr; 30(20):3090-6. PubMed ID: 22406277
[TBL] [Abstract][Full Text] [Related]
25. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
J Virol; 2020 May; 94(10):. PubMed ID: 32132233
[TBL] [Abstract][Full Text] [Related]
26. Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.
Ishikawa T; Wang G; Widman DG; Infante E; Winkelmann ER; Bourne N; Mason PW
Vaccine; 2011 Oct; 29(43):7444-55. PubMed ID: 21798299
[TBL] [Abstract][Full Text] [Related]
27. A Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in Pigs.
García-Nicolás O; Ricklin ME; Liniger M; Vielle NJ; Python S; Souque P; Charneau P; Summerfield A
Viruses; 2017 May; 9(5):. PubMed ID: 28531165
[TBL] [Abstract][Full Text] [Related]
28. Persistence of IgM Antibodies after Vaccination with Live Attenuated Japanese Encephalitis Vaccine.
Hills SL; Van Keulen A; Feser J; Panella A; Letson GW; Staples JE; Marfin AA; Brault AC
Am J Trop Med Hyg; 2020 Nov; 104(2):576-579. PubMed ID: 33236716
[TBL] [Abstract][Full Text] [Related]
29. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.
Lobigs M; Pavy M; Hall RA; Lobigs P; Cooper P; Komiya T; Toriniwa H; Petrovsky N
J Gen Virol; 2010 Jun; 91(Pt 6):1407-17. PubMed ID: 20130134
[TBL] [Abstract][Full Text] [Related]
30. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.
Fan YC; Chen JM; Chiu HC; Chen YY; Lin JW; Shih CC; Chen CM; Chang CC; Chang GJ; Chiou SS
PLoS Negl Trop Dis; 2012; 6(9):e1834. PubMed ID: 23029592
[TBL] [Abstract][Full Text] [Related]
31. The effects of Japanese encephalitis virus antibodies on Zika virus infection.
He X; Lang X; Yu J; Zhu L; Qin Z; Liu X; Chen P; Dai C; Chen T; Li X; Chen Y; Zhou D; Fang W; Xiao W; Zhang B; Xie Q; Wu Q; Zhao W
Med Microbiol Immunol; 2020 Apr; 209(2):177-188. PubMed ID: 32078028
[TBL] [Abstract][Full Text] [Related]
32. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
Sheng Z; Gao N; Cui X; Fan D; Chen H; Wu N; Wei J; An J
Vaccine; 2016 Nov; 34(47):5751-5757. PubMed ID: 27743649
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
[TBL] [Abstract][Full Text] [Related]
34. Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.
Li Z; Yang H; Yang J; Lin H; Wang W; Liu L; Zhao Y; Liu L; Zeng X; Yu Y; Li Y
Virus Res; 2014 Oct; 191():10-20. PubMed ID: 25091563
[TBL] [Abstract][Full Text] [Related]
35. Dengue virus isolation relying on antibody-dependent enhancement mechanism using FcγR-expressing BHK cells and a monoclonal antibody with infection-enhancing capacity.
Moi ML; Lim CK; Tajima S; Kotaki A; Saijo M; Takasaki T; Kurane I
J Clin Virol; 2011 Nov; 52(3):225-30. PubMed ID: 21824813
[TBL] [Abstract][Full Text] [Related]
36. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():597. PubMed ID: 29740424
[TBL] [Abstract][Full Text] [Related]
37. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
38. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
Paulke-Korinek M; Kollaritsch H; Kundi M; Zwazl I; Seidl-Friedrich C; Jelinek T
Vaccine; 2015 Jul; 33(30):3600-4. PubMed ID: 26036947
[TBL] [Abstract][Full Text] [Related]
39. Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells.
Moi ML; Lim CK; Chua KB; Takasaki T; Kurane I
PLoS Negl Trop Dis; 2012; 6(2):e1536. PubMed ID: 22389741
[TBL] [Abstract][Full Text] [Related]
40. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
